Lantern Pharma Inc.
NASDAQ:LTRN

Watchlist Manager
Lantern Pharma Inc. Logo
Lantern Pharma Inc.
NASDAQ:LTRN
Watchlist
Price: 3.5101 USD -0.56% Market Closed
Market Cap: 37.8m USD
Have any thoughts about
Lantern Pharma Inc.?
Write Note

Lantern Pharma Inc.
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lantern Pharma Inc.
Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Lantern Pharma Inc.
NASDAQ:LTRN
Operating Expenses
-$17.9m
CAGR 3-Years
-45%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Operating Expenses
-$21.9B
CAGR 3-Years
-4%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Operating Expenses
-$11.2B
CAGR 3-Years
-3%
CAGR 5-Years
4%
CAGR 10-Years
-8%
Amgen Inc
NASDAQ:AMGN
Operating Expenses
-$13.4B
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Expenses
-$4.9B
CAGR 3-Years
-10%
CAGR 5-Years
-16%
CAGR 10-Years
-15%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Expenses
-$7.8B
CAGR 3-Years
-23%
CAGR 5-Years
-16%
CAGR 10-Years
-17%

See Also

What is Lantern Pharma Inc.'s Operating Expenses?
Operating Expenses
-17.9m USD

Based on the financial report for Dec 31, 2023, Lantern Pharma Inc.'s Operating Expenses amounts to -17.9m USD.

What is Lantern Pharma Inc.'s Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-60%

Over the last year, the Operating Expenses growth was -24%. The average annual Operating Expenses growth rates for Lantern Pharma Inc. have been -45% over the past three years , -60% over the past five years .

Back to Top